Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
Rhea-AI Summary
Avanos Medical (NYSE: AVNS) will webcast a conference call to discuss fourth quarter and full year 2025 financial results on Feb. 24, 2026 at 9:00 a.m. ET. A news release with results will be issued before market open that day.
The call will be hosted by CEO Dave Pacitti and SVP/CFO Scott Galovan. Investors can join by phone, register for instant dial-in, or listen to a simultaneous webcast via the Avanos investors website. A replay will be available about two hours after the call and remain accessible for one week.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
AVNS was up 0.95% ahead of the webcast notice, while key peers showed mixed to positive moves (e.g., CTKB in scanner up 2.58%), but with no broad, confirmed sector rotation.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 27 | Earnings call scheduling | Neutral | -0.8% | Announced Q3 2025 webcast timing and logistics before detailed results. |
| Jul 24 | Earnings call scheduling | Neutral | -1.9% | Set date and access details for Q2 2025 earnings conference call. |
| Apr 28 | Earnings call scheduling | Neutral | +2.8% | Outlined timing and speakers for Q1 2025 financial results webcast. |
| Feb 19 | Earnings call scheduling | Neutral | +0.5% | Announced Q4 and full year 2024 earnings call date and access details. |
| Oct 23 | Earnings call scheduling | Neutral | -0.6% | Provided webcast and dial‑in information for Q3 2024 results discussion. |
Similar conference-call scheduling releases have produced minimal stock moves, with an average same‑tag reaction of 0.02%, suggesting these notices are typically low‑impact catalysts.
Over the past five quarters, Avanos has consistently pre‑announced webcast details for its quarterly and year‑end earnings calls, usually about a week in advance. These ‘conferences,earnings’ notices, including Q1–Q4 2024 and Q1–Q3 2025, outlined timing, leadership participants, and replay logistics. Market reactions to these scheduling announcements have stayed close to flat, with moves between roughly -1.9% and +2.83%. Today’s fourth quarter and full year 2025 webcast notice follows this established communications pattern.
Historical Comparison
Past ‘conferences,earnings’ scheduling releases for AVNS moved the stock by an average of 0.02%, indicating that today’s Q4/FY25 webcast notice fits a historically low‑impact pattern.
The company has maintained a steady quarterly cadence of webcast announcements tied to earnings, reinforcing a consistent investor‑communication framework from 2024 through 2025.
Market Pulse Summary
This announcement sets the timetable and access details for Avanos’ fourth quarter and full year 2025 earnings discussion on Feb. 24, 2026. Historically, similar ‘conferences,earnings’ notices around webcast logistics caused only minor share‑price moves, with an average reaction of 0.02%. Investors evaluating this update typically focused more on the forthcoming earnings release itself—such as revenue trends, profitability, and guidance—alongside recent restructuring steps and institutional ownership changes disclosed in prior filings.
AI-generated analysis. Not financial advice.
The conference call will be hosted by Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer.
To instantly join the conference call by phone, use the following link to register close to the call start time: https://emportal.ink/46QTVgQ
After registering, the system will call you and automatically connect you to the conference call. Alternatively, you may join the call by dialing 1-646-357-8785 or 1-800-836-8184 and you will be connected to the call by an operator.
A simultaneous webcast of the call and the related presentation will be accessible via the Investors section of the Avanos Medical website, https://avanos.investorroom.com/. The replay will be accessible within two hours of the end of the call and will be available for one week. Alternatively, you may dial 1-646-517-4150 or 1-888-660-6345 and enter passcode 71930#.
About Avanos Medical, Inc.
Avanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-webcast-conference-call-discussing-fourth-quarter-and-full-year-2025-financial-results-302688973.html
SOURCE Avanos Medical
FAQ
When is Avanos Medical (AVNS) hosting the Q4 and full year 2025 earnings call?
How can investors join the Avanos Medical (AVNS) webcast and conference call on Feb. 24, 2026?
Who will host Avanos Medical's (AVNS) Feb. 24, 2026 earnings call and what roles do they hold?
Will a replay of the Avanos Medical (AVNS) Feb. 24, 2026 call be available and for how long?
Where will Avanos Medical (AVNS) publish the Feb. 24, 2026 financial results and related presentation?
